Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
Latest reported DSGN revenue for 2025-12-31 was $0. Net income was -$69.8M. DSGN currently screens at market cap $214.0M.
Use this DSGN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the DSGN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the DSGN SEC filings page. Lician reads the product cache first so this HTML stays unique to Design Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full DSGN income, balance, and cash tables.